Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease

Barone, Maria Vittoria; Gimigliano, Anna; Castoria, Gabriella; Paolella, Giovanni; Maurano, Francesco; Paparo, Franco; Maglio, Maria; Mineo, Alba; Miele, Erasmo; Nanayakkara, Merlin; Troncone, Riccardo; Auricchio, Salvatore
April 2007
Gut;Apr2007, Vol. 56 Issue 4, p480
Academic Journal
Background: Gliadins, a family of wheat proteins, are central to the pathogenesis of celiac disease (CD). In addition to 'immunogenic' effects, gliadin directly affects cultured cells and intestine preparations, and produces damage in vivo, via a separate 'toxic' peptide, such as A-gliadin p31-43 (P31-43). Aims: Understanding the molecular mechanisms underlying direct non T-cell mediated effects of gliadin peptides, and assessing their potential role in promoting CD. Method: Gliadin effects were tested on a number of cell lines and on cultured mucosa samples by evaluating cytoskeleton rearrangements, endocytosis, proliferation and apoptosis. Standard biochemical methods were used to assess prolonged epidermal growth factor receptor (EGFR) activation. Results: Crude gliadin peptic-tryptic peptides (PIG], or P31-43 alone, fully reproduce the effects of epidermal growth factor (EGF] on actin cytosketon, cell cycle and cell proliferation of various cell lines. Inhibitor studies demonstrate the role of EGFR in the early response to gliadin exposure, pointing to activation of the EGFR pathway. Peptide P31-43 is not similar to any EGFR ligand, but can delay inactivation of the EGFR interfering with its endocytosis. Gliadin-induced delay of EGFR endocytosis in cultured intestinal biopsies, together with S-phase entry of epithelial intestinal cells, confirm a role for EGFR activation in CD. Conclusion: The ability of gliadin peptides to delay EGFR inactivation through interference with the endocytic pathway suggests a model where gliadin fragments amplify the effects of trace amounts of EGF, and possibly of other growth factors, by prolonging receptor activation. The results, using cultures of coeliac intestinal biopsies, highlight the role of the EGF pathway in establishing and maintaining the typical atrophic and proliferative alterations of the small intestine in CD.


Related Articles

  • Gliadin Peptide P31-43 Localises to Endocytic Vesicles and Interferes with Their Maturation. Barone, Maria Vittoria; Nanayakkara, Merlin; Paolella, Giovanni; Maglio, Mariantonia; Vitale, Virginia; Troiano, Raffaele; Ribecco, Maria Teresa Silvia; Lania, Giuliana; Zanzi, Delia; Santagata, Sara; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore // PLoS ONE;2010, Vol. 5 Issue 8, p1 

    Background: Celiac Disease (CD) is both a frequent disease (1:100) and an interesting model of a disease induced by food. It consists in an immunogenic reaction to wheat gluten and glutenins that has been found to arise in a specific genetic background; however, this reaction is still only...

  • Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins. De Vincenzi, Massimo; Vincentini, Olimpia; Nardo, Giovanni Di; Boirivant, Monica; Gazza, Laura; Pogna, Norberto // European Journal of Nutrition;Jun2010, Vol. 49 Issue 4, p251 

    Celiac disease (CD) is a permanent intolerance to wheat prolamins and related proteins displayed by genetically susceptible individuals. Blocking or modulation of CD-specific T cell response by altered prolamin peptides are currently considered as a potential alternative to the only effective...

  • Combined effect of gefitinib ('Iressa ',ZD1839) and targeted radiotherapy with [sup211] At-EGF. Sundberg, Åsa Lijegren; Almqvist, Ylva; Orlava, Anna; Blomquist, Erik; Jensen, Holger J.; Gedda, Lars; Tolmachev, Vladimir; Carlsson, Jörgen // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 10, p1348 

    The EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitor) gefitinib [‘Iressa’(trademark of the AstraZeneca group of companies), ZD1839] increases the cellular uptake of radiolabelled epidermal growth factor (EGF). We investigated gefitinib treatment combined with...

  • Presence of celiac disease epitopes in modern and old hexaploid wheat varieties: wheat breeding may have contributed to increased prevalence of celiac disease. van Broeck, Hetty C.; de Jong, Hein C.; Salentijn, Elma M. J.; Dekking, Liesbeth; Bosch, Dirk; Hamer, Rob J.; Gilissen, Ludovicus J. W. J.; van der Meer, Ingrid M.; Smulders, Marinus J. M. // Theoretical & Applied Genetics;Nov2010, Vol. 121 Issue 8, p1527 

    Gluten proteins from wheat can induce celiac disease (CD) in genetically susceptible individuals. Specific gluten peptides can be presented by antigen presenting cells to gluten-sensitive T-cell lymphocytes leading to CD. During the last decades, a significant increase has been observed in the...

  • Lymnaea EGF and Gigantoxin I, Novel Invertebrate Members of the Epidermal Growth Factor Family. Hermann, P. M.; Schein, C. H.; Nagle, G. T.; Wildering, W. C. // Current Pharmaceutical Design;Dec2004, Vol. 10 Issue 31, p3885 

    In this review, we compare the sequence and structural relationships of two epidermal growth factor (EGF) family related proteins that have recently been discovered in invertebrate species. The first is L-EGF, a secreted growth factor from the gastropod mollusk Lymnaea stagnalis. The second is a...

  • High-Level Expression and Purification of Human Epidermal Growth Factor with SUMO Fusion in Escherichia coli. Zhijian Su; Yadong Huang; Quannan Zhou; Zhiling Wu; Xiaoping Wu; Qing Zheng; Changcai Ding; Li, Xiaokun // Protein & Peptide Letters;Aug2006, Vol. 13 Issue 8, p785 

    Human epidermal growth factor (hEGF) can stimulate the division of various cell types and has potential clinical applications. However, the high expression of active hEGF in Escherichia coli has not been successful, as the protein contains three intra-molecular disulfide bonds that are difficult...

  • A metalloprotease-disintegrin, MDC9/meltrin-?/ADAM9 and PKCd are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Izumi, Yasushi; Hirata, Michinari; Hasuwa, Hidetoshi; Iwamoto, Ryo; Umata, Toshiyuki; Miyado, Kenji; Tamai, Yoko; Kurisaki, Tomohiro; Sehara-Fujisawa, Atsuko; Ohno, Shigeo; Mekada, Eisuke // EMBO Journal;12/15/98, Vol. 17 Issue 24, p7260 

    The ectodomains of many proteins located at the cell surface are shed upon cell stimulation. One such protein is the heparin-binding EGF-like growth factor (HB-EGF) that exists in a membrane-anchored form which is converted to a soluble form upon cell stimulation with TPA, an activator of...

  • Short form of the heparin-binding EGF-like growth factor: Communication II. Loukianov, E. V.; Kozlov, Yu. V. // Molecular Biology;Sep2006, Vol. 40 Issue 5, p797 

    The structure of the green monkey Chlorocebus aethiops heparin-binding EGF-like growth factor (HB-EGF) gene was compared with that of the corresponding human gene. Exon 3a, characteristic of the short form of HB-EGF (SF-HB-EGF), was mapped between exons 3 and 4, approximately 700 bp away from...

  • Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor. Ellenrieder, Volker; Jin-San Zhang; Kaczynski, Joanna; Urrutia, Raul // EMBO Journal;5/15/2002, Vol. 21 Issue 10, p2451 

    A Sin3-interacting domain (SID) originally described in Mad proteins is necessary for both transcriptional repression and growth suppression by these transcription factors. We recently reported that a structurally and functionally related Mad1-like SID is also present in five Sp1-like repressor...


Read the Article


Sign out of this library

Other Topics